Live tape
Top 8, mentions 7d6,024META1,633 mentions▲ +0.06GOOGL1,165 mentions▲ +0.03NVDA782 mentions▲ +0.09TSLA524 mentions▲ +0.05MSFT523 mentions▲ +0.06AMZN484 mentions▲ +0.04SPY481 mentions▲ +0.03AAPL432 mentions▲ +0.06

Equity · Healthcare

INSP

NYSE

Inspire Medical Systems, Inc.

$51 −0.93% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart
Our own end-of-day closes 11 sessions
$54 $46 2 Jul 17 Jul

The line runs $47 on 2 July through $51 on 17 July, on a scale from $46 to $54. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of INSP over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 11 sessions over that window: $47 on 2 July 2026 through $51 on 17 July 2026.

Market cap $1.5B
P/E (TTM) 11.3
52-week range $40 – $144
Avg volume 176.3K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 17, 2026

INSP insider trades

SEC Form 4

INSP has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 2 December 2025.

Date Insider Type Shares Value
02 Dec 2025 mcCormick Shawn Sell 1,200 $167K
28 Nov 2025 mcCormick Shawn Sell 2,000 $255K
29 Aug 2025 Buchholz Richard Chief Financial Officer Sell 11,000 $1.03M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
14 Oct 2025 Melenikiotou Georgia Award 229 $18K
14 Oct 2025 Ellis Gary Lee Award 372 $29K
14 Oct 2025 Broader Shelley G Award 245 $19K
14 Oct 2025 Tansey Casey M Award 221 $17K

INSP reported financials

SEC EDGAR XBRL

INSP reported revenue of $912.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was $145.4M.

Figure Reported Period
Revenue $912.0M 31 Dec 2025 fiscal year
Net income $145.4M 31 Dec 2025 fiscal year
Diluted EPS $4.89 31 Dec 2025 fiscal year
Total assets $926.0M 30 Jun 2026 at period end
Total equity $825.6M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

INSP earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.01 —
31 Mar 2026 Q1 2026 $-0.39 —
31 Dec 2025 FY 2025 $4.89 —
30 Sep 2025 Q3 2025 $0.34 —
30 Jun 2025 Q2 2025 $-0.12 —
31 Mar 2025 Q1 2025 $0.10 —
31 Dec 2024 FY 2024 $1.75 —
30 Sep 2024 Q3 2024 $0.60 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

INSP institutional holders

SEC Form 13F

6 of the 45 institutional funds we track reported a INSP position for the quarter ended 30 Jun 2026 — a combined $199.9M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Added +501.6% shares 1,856,800 $80.9M
D. E. Shaw & Co. Held (±25%) +23.7% shares 1,470,462 $65.6M
Citadel Advisors Added +28.5% shares 506,334 $22.6M
Renaissance Technologies Held (±25%) −9.4% shares 426,000 $19.0M
Tudor Investment Corp Held (±25%) +1.1% shares 169,095 $7.5M
Millennium Management Trimmed −75.6% shares 94,149 $4.2M
Balyasny Asset Management Exited
Bridgewater Associates Exited
Man Group Exited
Two Sigma Investments Exited

Source: SEC EDGAR 13F filings

INSP fails-to-deliver

SEC CNS data

On 24 Aug 2026, 13,400 shares of INSP failed to deliver (about $836K).

Settlement date Shares failed Notional % of shares out
24 Aug 2026 13,400 $836K 0.046%
20 Aug 2026 80 $5K <0.001%

Source: SEC fails-to-deliver (CNS) data